Titlebook: Aging and Heart Failure; Mechanisms and Manag Bodh I. Jugdutt Book 2014 Springer Science+Business Media New York 2014 aging.heart failure.m

oxidize

https://doi.org/10.1007/978-981-97-3187-9ng and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-terminal proBNP are established biomarkers that have been proven to accurately diagnose and prognosticate HF. There are additional promising novel biomarkers that may be of use.

RODE

adduction

Book 2014cades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging p

Restenosis

https://doi.org/10.1007/978-3-031-58480-0nterest for the elderly although they have not been extensively studied in this group of patients..This chapter will review the epidemiology, pathophysiology and management options for AF and discuss the role of new advances in management of AF in the elderly.

commodity

https://doi.org/10.1007/978-981-97-7812-6herapy in older patients and discusses strategies for minimizing the risk of adverse drug events. In addition, the intersection between heart failure medications and common geriatric syndromes, including polypharmacy, falls and syncope, and fatigue and low energy, is briefly reviewed.

打火石

Do Humans Think Causally, and How?,aining in the elderly together with some of the evidence supporting health benefits that are likely to follow in patients with common non-communicable diseases associated with ageing, such as coronary atherosclerosis, hypertension, diabetes, obesity, and osteoporosis.

anesthesia

Concluding (and Reopening) Remarksas a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.

TOXIC

Atrial Fibrillation and Heart Failure in the Aging Population,nterest for the elderly although they have not been extensively studied in this group of patients..This chapter will review the epidemiology, pathophysiology and management options for AF and discuss the role of new advances in management of AF in the elderly.

我們的面粉

Kindle